272 related articles for article (PubMed ID: 22572101)
1. YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes.
Batinic K; Höbaus C; Grujicic M; Steffan A; Jelic F; Lorant D; Hörtenhuber T; Hoellerl F; Brix JM; Schernthaner G; Koppensteiner R; Schernthaner GH
Atherosclerosis; 2012 Jun; 222(2):557-63. PubMed ID: 22572101
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
[TBL] [Abstract][Full Text] [Related]
3. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
[TBL] [Abstract][Full Text] [Related]
4. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
[TBL] [Abstract][Full Text] [Related]
5. Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease.
Wu S; Hsu LA; Cheng ST; Teng MS; Yeh CH; Sun YC; Huang HL; Ko YL
Int J Mol Sci; 2014 Dec; 15(12):22421-37. PubMed ID: 25486056
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes.
Hansen M; Nielsen AR; Vilsbøll T; Lund A; Krarup T; Knop FK; Vestergaard H
Pancreas; 2012 Nov; 41(8):1316-8. PubMed ID: 22647735
[TBL] [Abstract][Full Text] [Related]
7. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
9. Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes.
Lin CH; Li HY; Jiang YD; Chang TJ; Chuang LM
Clin Endocrinol (Oxf); 2013 Aug; 79(2):185-91. PubMed ID: 22901243
[TBL] [Abstract][Full Text] [Related]
10. YKL-40 in type 2 diabetic patients with different levels of albuminuria.
Brix JM; Höllerl F; Koppensteiner R; Schernthaner G; Schernthaner GH
Eur J Clin Invest; 2011 Jun; 41(6):589-96. PubMed ID: 21158852
[TBL] [Abstract][Full Text] [Related]
11. Serum YKL-40 levels are associated with type 2 diabetes mellitus in patients with obstructive sleep apnea syndrome.
Sun L; Liu JY; Li LR
Genet Mol Res; 2015 Aug; 14(3):8919-25. PubMed ID: 26345823
[TBL] [Abstract][Full Text] [Related]
12. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
[TBL] [Abstract][Full Text] [Related]
13. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
14. YKL-40 levels are independently associated with albuminuria in type 2 diabetes.
Røndbjerg AK; Omerovic E; Vestergaard H
Cardiovasc Diabetol; 2011 Jun; 10():54. PubMed ID: 21696606
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
16. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.
Mathiasen AB; Harutyunyan MJ; Jørgensen E; Helqvist S; Ripa R; Gøtze JP; Johansen JS; Kastrup J
Scand J Clin Lab Invest; 2011 Sep; 71(5):439-47. PubMed ID: 21827355
[TBL] [Abstract][Full Text] [Related]
17. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease.
Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
Atherosclerosis; 2010 Jun; 210(2):590-5. PubMed ID: 20056225
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
[TBL] [Abstract][Full Text] [Related]
19. Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension.
Ma WH; Wang XL; Du YM; Wang YB; Zhang Y; Wei DE; Guo LL; Bu PL
BMC Cardiovasc Disord; 2012 May; 12():35. PubMed ID: 22642467
[TBL] [Abstract][Full Text] [Related]
20. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
Thomsen SB; Gjesing AP; Rathcke CN; Ekstrøm CT; Eiberg H; Hansen T; Pedersen O; Vestergaard H
PLoS One; 2015; 10(7):e0133672. PubMed ID: 26197239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
